Neuro-Oncology Reviews

Volume 25 Number 1
15 January 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 1, 15 January

Cano A, Ettcheto M, Bernuz M, Puerta R, Esteban de Antonio E, Sánchez-López E, Souto EB, Camins A, Martí M, Pividori MI, Boada M, Ruiz A.
Extracellular vesicles, the emerging mirrors of brain physiopathology.
Int J Biol Sci. 2023 Jan 1;19(3):721-743
. doi: 10.7150/ijbs.79063. PMID: 36778117. Review. ˍ

Laurenge A, Huillard E, Bielle F, Idbaih A.
Cell of Origin of Brain and Spinal Cord Tumors.
Adv Exp Med Biol. 2023 Jan 2, 2023;1394:85-101
. doi: 10.1007/978-3-031-14732-6_6. PMID: 36587383. Review˰ ˍ

Medikonda R, Pant A, Lim M.
Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
Adv Exp Med Biol. 2023 Jan 2, 2023;1394:73-84
. doi: 10.1007/978-3-031-14732-6_5. PMID: 36587382. Review˰ ˍ

Shobeiri P, Seyedmirzaei H, Kalantari A, Mohammadi E, Rezaei N, Hanaei S.
The Epidemiology of Brain and Spinal Cord Tumors.
Adv Exp Med Biol. 2023 Jan 2, 2023;1394:19-39
. doi: 10.1007/978-3-031-14732-6_2. PMID: 36587379. Review˰ ˍ

Walbert T, Stec NE.
Palliative care in brain tumors.
Handb Clin Neurol. 2023 Jan 2, 2023;191:69-80
. doi: 10.1016/B978-0-12-824535-4.00011-2. PMID: 36599516. Review˰ ˍ

Yoon WS, Chung DS.
Advanced T and NK Cell Therapy for Glioblastoma.
J Korean Neurosurg Soc. 2023 Jan 2
. doi: 10.3340/jkns.2022.0267. PMID: 36588388. Review. ˍ

Chai R, Fang S, Pang B, Liu Y, Wang Y, Zhang W, Jiang T.
Molecular pathology and clinical implications of diffuse glioma.
Chin Med J (Engl). 2023 Jan 3
. doi: 10.1097/CM9.0000000000002446. PMID: 36728558. Review. ˍ

Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P.
Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy.
J Clin Invest. 2023 Jan 3, 2023;133(1):e163446
. doi: 10.1172/JCI163446. PMID: 36594466. Review. ˍ

Friedmann-Morvinski D, Hambardzumyan D.
Monocyte-neutrophil entanglement in glioblastoma.
J Clin Invest. 2023 Jan 3, 2023;133(1):e163451
. doi: 10.1172/JCI163451. PMID: 36594465. Review. ˍ

Li S, Wang C, Chen J, Lan Y, Zhang W, Kang Z, Zheng Y, Zhang R, Yu J, Li W.
Signaling pathways in brain tumors and therapeutic interventions.
Signal Transduct Target Ther. 2023 Jan 4, 2023;8(1):8
. doi: 10.1038/s41392-022-01260-z. PMID: 36596785. Review. ˍ

Shu L, Yu D, Jin F.
Healthy dietary patterns, foods, and risk of glioma: A systematic review and meta-analysis of observational studies.
Front Nutr. 2023 Jan 4, 2022;9:1077452
. doi: 10.3389/fnut.2022.1077452. PMID: 36687697. Review, Meta-analysis. ˍ

Vetkas A, Germann J, Boutet A, Samuel N, Sarica C, Yamamoto K, Santyr B, Cheyuo C, Conner CR, Lang SM, Lozano AM, Ibrahim GM, Valiante T, Kongkham PN, Kalia SK.
Laser interstitial thermal therapy for the treatment of insular lesions: A systematic review.
Front Neurol. 2023 Jan 4, 2022;13:1024075
. doi: 10.3389/fneur.2022.1024075. PMID: 36686528. Review. ˍ

Ninatti G, Pini C, Gelardi F, Sollini M, Chiti A.
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review.
Cancers (Basel). 2023 Jan 5;15(2):364
. doi: 10.3390/cancers15020364. PMID: 36672314. Review. ˍ

Roux A, Zanello M, Simboli GA, Varlet P, Tauziède-Espariat A, Beccaria K, Blauwblomme T, Puget S, Oppenheim C, Dangouloff-Ros V, Boddaert N, Dhermain F, Dufour C, Grill J, Chrétien F, Pallud J.
Clinico-radio-histo-molecular and neurocognitive characteristics of diffuse gliomas in adolescent and young adults. A comprehensive review.
Oncology. 2023 Jan 5
. doi: 10.1159/000528588. PMID: 36603564. Review˰ ˍ

Halfpenny AM, Wood M.
Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors.
Pediatr Neurosurg. 2023 Jan 6
. doi: 10.1159/000528957. PMID: 36617415. Review. ˍ

Tripathy A, John V, Wadden J, Kong S, Sharba S, Koschmann C.
Liquid biopsy in pediatric brain tumors.
Front Genet. 2023 Jan 6, 2022;13:1114762∟. doi: 10.3389/fgene.2022.1114762
. PMID: 36685825. Review. ˍ

Wang Y, Bastiancich C, Newland B.
Injectable local drug delivery systems for glioblastoma: a systematic review and meta-analysis of progress to date.
Biomater Sci. 2023 Jan 6
. doi: 10.1039/d2bm01534j. PMID: 36655634. Review, Meta-analysis. ˍ

Ellingson BM, Wen PY, Chang SM, van den Bent M, Vogelbaum MA, Li G, Li S, Kim J, Youssef G, Wick W, Lassman AB, Gilbert MR, de Groot JF, Weller M, Galanis E, Cloughesy TF.
Objective response rate (ORR) targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival.
Neuro Oncol. 2023 Jan 7:noad002
. doi: 10.1093/neuonc/noad002. PMID: 36617262. Review. ˍ

Horbinski C, Nabors LB, Portnow J, Baehring J, Bhatia A, Bloch O, Brem S, Butowski N, Cannon DM, Chao S, Chheda MG, Fabiano AJ, Forsyth P, Gigilio P, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Merrell R, Mrugala MM, Nagpal S, Nedzi LA, Nevel K, Nghiemphu PL, Parney I, Patel TR, Peters K, Puduvalli VK, Rockhill J, Rusthoven C, Shonka N, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow S.
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
J Natl Compr Canc Netw. 2023 Jan 10, 2023;21(1):12-20
. doi: 10.6004/jnccn.2023.0002. PMID: 36634606. Guidelines. ˍ

Oh KS, Mahalingam M.
Melanoma and Glioblastoma-Not a Serendipitous Association.
Adv Anat Pathol. 2023 Jan 10
. doi: 10.1097/PAP.0000000000000393. PMID: 36624550. Review˰ ˍ

Aseel A, McCarthy P, Mohammed A.
Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis.
J Neuroimaging. 2023 Jan 11
. doi: 10.1111/jon.13080. PMID: 36631883. Review, Meta-analysis˰ ˍ

Bernstock JD, Blitz S, Kang KD, Friedman GK.
Intraventricular immunovirotherapy; a translational step forward.
Oncotarget. 2023 Jan 12, 2023;14:40-43
. doi: 10.18632/oncotarget.28343. PMID: 36634220. Perspective. ˍ

Caffo M, Minutoli L, Tabouret E, Barresi V.
Editorial: Novel diagnostic and therapeutic strategies in the management of cerebral gliomas.
Front Oncol. 2023 Jan 12;12:1115410. doi: 10.3389/fonc.2022.1115410. PMID: 36713581. Editorial.

Capper D, Reifenberger G, French PJ, Schweizer L, Weller M, Touat M, Niclou SP, Euskirchen P, Haberler C, Hegi ME, Brandner S, Le Rhun E, Rudà R, Sanson M, Tabatabai G, Sahm F, Wen PY, Wesseling P, Preusser M, van den Bent MJ.
EANO guideline on rational molecular testing of gliomas, glioneuronal and neuronal tumors in adults for targeted therapy selection.
Neuro Oncol. 2023 Jan 12:noad008
. doi: 10.1093/neuonc/noad008. PMID: 36632791. Guidelines. ˍ

Johnson KJ, Bauchet L, Francis SS, Hainfellner JA, Kruchko C, Lau CC, Ostrom QT, Scheurer ME, Yuan Y.
Pediatric brain tumors: Origins, epidemiology, and classification - The 2022 Brain Tumor Epidemiology Consortium meeting report.
Clin Neuropathol. 2023 Jan 12
. doi: 10.5414/NP301520. PMID: 36633374. Meeting report˰ ˍ

Rodriguez-Almaraz JE, Butowski N.
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis).
Curr Treat Options Oncol. 2023 Jan 12
. doi: 10.1007/s11864-022-01047-y. PMID: 36633803. Review. ˍ

Dalle Ore C, Coleman-Abadi C, Gupta N, Mueller S.
Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas.
Pediatr Neurosurg. 2023 Jan 13
. doi: 10.1159/000529099. PMID: 36642062. Review. ˍ

Gombolay GY, Gopalan N, Bernasconi A, Nabbout R, Megerian JT, Siegel B, Hallman-Cooper J, Bhalla S, Gombolay MC.
Review of Machine Learning and Artificial Intelligence (ML/AI) for the Pediatric Neurologist.
Pediatr Neurol. 2023 Jan 13;141:42-51
. doi: 10.1016/j.pediatrneurol.2023.01.004. PMID: 36773406. Review˰ ˍ

Kotecha R, Odia Y, Khosla AA, Ahluwalia MS.
Key Clinical Principles in the Management of Glioblastoma.
JCO Oncol Pract. 2023 Jan 13:OP2200476
. doi: 10.1200/OP.22.00476. PMID: 36638331. Review. ˍ

Lu Q, Lu X, Zhang Y, Huang W, Zhou H, Li T.
Recent advances in ferroptosis and therapeutic strategies for glioblastoma.
Front Mol Biosci. 2023 Jan 13, 2022;9:1068437
. doi: 10.3389/fmolb.2022.1068437. PMID: 36710875. Review. ˍ

Shonka NA, Horbinski CM.
Reconciling the Contemporary Molecular Diagnosis of Glioblastoma With Past Clinical Trial Data.
JCO Oncol Pract. 2023 Jan 13:OP2200784. doi: 10.1200/OP.22.00784. PMID: 36638329. Comment˰ ˍ
Refers to:
Kotecha R, et al., Key Clinical Principles in the Management of Glioblastoma.
JCO Oncol Pract. 2023 Jan 13:OP2200476
. doi: 10.1200/OP.22.00476. PMID: 36638331. Review. ˍ